In recent years, lead halide perovskite nanocrystals (NCs) have attracted significant attention in both fundamental research and commercial applications because of their excellent optical and optoelectrical properties. However, the protective ligands on the surface of the perovskite NCs could be easily removed after the tedious process of centrifugation, separation, and dispersion, which greatly hampers their stability against light, heat, moisture, and oxygen and limits their practical applications. Here, we report a new post-processing free strategy (i.e., without centrifugation, separation, and dispersion process) of using an ultraviolet (UV)-polymerizable acrylic monomer of lauryl methacrylate as the solvent to synthesize CsPbBr3 NCs, and then adding polyester polyurethane acrylate oligomer, monomer (IBOA), and initiator for direct UV polymerization to fabricate NC–polymer composite films. These films exhibited an improved photoluminescence quantum yield (85–90%) than classic NC films (40–50%), which were processed using octadecene (ODE) as the solvent for NC synthesis and postprocessed for UV polymerization. Significantly, the as-fabricated films by post-processing free strategy exhibited excellent photostability against strong Xe lamp illumination; while the other films using classic methods were quickly photodegraded. Meanwhile, these NC–polymer composite films showed good stability against moisture and heating when aging in water at 50 °C for over 200 h. These films, along with K2SiF6:Mn4+ (KSF) phosphor emitters, were used as downconverters for blue light-emitting diodes in liquid-crystal displays with a wide color gamut of 115% in the International Commission on Illumination (CIE) 1931 color space. This work provides a facile and effective strategy for the preparation of ultrastable and bright color-conversion NC films for the development of the next-generation wide color gamut displays.

No abstract

ISG15 (ISG15 ubiquitin-like modifier), a ubiquitin-like protein, is one of the major type I IFN (interferon) effector systems. ISG15 can be conjugated to target proteins (ISGylation) via the stepwise action of E1, E2, and E3 enzymes. Conjugated ISG15 can be removed (deISGylated) from target proteins by USP18 (ubiquitin-specific peptidase 18). Here we investigated the role of deISGylation by USP18 in regulating autophagy and EGFR degradation in cells treated with type I IFNs. We show that type I IFN induced expression of ISG15 leads to ISGylation of BECN1 at Lys117, as well as Lys263, Lys265, and Lys266 which competes with Lys63 ubiquitination of BECN1. We demonstrate that ISGylation of BECN1 at Lys117, as well as Lys263, Lys265, and Lys266 serve an important role in negative regulation of intracellular processes including autophagy and EGFR degradation that are critically dependent upon the activity of class III PtdIns 3-kinase. Our studies provide fundamental new mechanistic insights into the innate immunity response implemented by type I IFNs.